(Sharecast News) - Medical technology company Surgical Innovations announced a new United States distribution agreement with Microline Surgical for its range of 'YelloPort+Plus' and 'YelloPort Elite' access devices.
The AIM-traded firm said the five-year agreement would bring "significant opportunity" for growth in the US trocar market.
It said Microline's sales and marketing structure was ideally placed to leverage its experience with 'Resposable' surgical instruments to effectively drive US sales of YelloPort+Plus and YelloPort Elite.
Microline, based near Boston, designs, manufactures and distributes instruments aimed at the minimally-invasive surgery market.
Its portfolio of products was said to be "complementary" to those offered by Surgical Instruments with a focus on the 'resposable' ethos of cost and sustainability.
Surgical Innovations said it had a long established relationship with Microline, where it has an exclusive Great Britain distribution agreement for Microline instruments that are complementary to its own branded range.
"The United States accounts for almost half of the worldwide trocar market," said group development director Adam Power.
"Microline has a direct sales team with considerable experience in the selling of Resposable surgical devices.
"Microline and Surgical Innovations, through its UK subsidiary Elemental Healthcare, share a long history of synergy and growth and we are very excited to replicate this successful relationship in the United States."
At 1538 GMT, shares in Surgical Innovations Group were up 12.2% at 2.3p.
Surgical Innovations (SUN)18 Apr 2024 16:52
LONDON MARKET CLOSE: Stocks recover some of recent Fed talk losses
(Alliance News) - Stock prices in London closed up on Thursday, despite the prospect of higher for longer US interest rates hanging over stocks, while...